Cancer Science & Therapy

Clinical Features of the Gastric Signet Ring Cell Carcinoma Including CA 19-9, CEA and CRP Levels

Abstract

Bulent Kaya, Hasan Abuoglu, Cengiz Eris, Mehmet Kamil Yildiz, Orhan Bat, Mehmet Odabasi, Nuriye Esen Bulut, Alper Sahbaz, Aziz Sener, Azamet Çezik and Umit Topaloglu

Aim: The aim of this study was to evaluate the clinicopathological features and prognosis of gastric Signet Ring Cell Carcinoma (SRCC) including measurement of tumor markers (CEA, CA 19-9) and CRP.

Material and method: There were 19 patients with histopathological diagnosis of signet ring cell carcinoma of the stomach. Clinicopathological parameters, including gender and age of the patients, duration of symptoms, size and location of tumors, depth of invasion (T stage), lymph node metastasis status (N stage), distant metastasis (M status) and operative details, were collected retrospectively. CEA, CA 19-9 and CRP levels were measured in all patients.

Results: The mean age of the patients was 63.74 ± 15.07 (range 37-90 years). Median survival time was 17.4 ± 10.7 month (range 4-48 months). The mean CA 19-9 level was 14.4 ± 23.1 (0.8-101.6), CEA level was 91.9 ± 227.2 (0.46-989) and CRP level was 1.79 ± 1.19 (0.3-3.7). Sixteen patients were classified as stage III or IV disease. Five patients were operated with total gastrectomy and 9 patients with gastroenterostomy due to unresectable tumor.

Conclusion: Clinicopathological behavior of gastric SRCC is still debated. In this serial, most of the patients with gastric SRCC were diagnosed and treated in last stages of their diseases. Although CA 19-9 and CEA levels were inceased in some patients with SRCC, diagnostic value of these markers is debated.Another marker CRP was found normal in most of the patients with gastric SRCC in this serial.

 

PDF